US Patent 10981901 Heterocyclic amides useful as protein modulators
Patent 10981901 was granted and assigned to GlaxoSmithKline on April, 2021 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
April 5, 2017
0
Date of Patent
April 20, 2021
0
Patent Application Number
16091189
0
Patent Inventor Names
Jianxing Kang
0
Joseph J. Romano
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10981901 Heterocyclic amides useful as protein modulators
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
